Wedbush Recommends Buying Sangamo BioSciences (SGMO) on Weakness
Wedbush analyst Liana Moussatos is out defending Sangamo BioSciences (NASDAQ: SGMO) mid-day with shares getting sliced to the tune of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
